Rakovina Therapeutics Announces $1.5 Million Private Placement
VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through…
Read the full articleYou might also wanna read
AI accelerates search for cancer therapeutics in Korea
Artificial intelligence (AI) has helped SK Telecom and SK Biopharmaceuticals identify promising early compounds for a targeted cancer therap
Chai Discovery triples to $3.8B in 7 months as OpenAI-backed drug designer lands $400M after Novartis deal
Chai Discovery has raised $400 million in a Series C round that values the AI drug discovery company…
STAT+: Roche drug sets new standard for KRAS-driven lung cancer
Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
Aureka offers open-source AI module for drug discovery
Aureka offers open-source AI module for drug discovery Phil.Taylor Wed, 08/07/2026 - 13:18
Paul Hastings Advises Ligand Pharmaceuticals on Its $700 Million Convertible Senior Notes Offering
Paul Hastings LLP advised Ligand Pharmaceuticals Incorporated (Nasdaq: LGND), a biopharmaceutical company enabling scientific advancement th
Comments
Sign in to join the conversation.
No comments yet. Be the first.